Preliminary Toxicological Analysis in a Safe-by-Design and Adverse Outcome Pathway-Driven Approach on Different Silver Nanoparticles: Assessment of Acute Responses in A549 Cells - SYstèmes Moléculaires et nanoMatériaux pour l’Energie et la Santé Accéder directement au contenu
Article Dans Une Revue Toxics Année : 2023

Preliminary Toxicological Analysis in a Safe-by-Design and Adverse Outcome Pathway-Driven Approach on Different Silver Nanoparticles: Assessment of Acute Responses in A549 Cells

Résumé

Silver nanoparticles (Ag NPs) are among the most widely used metal-based nanomaterials (NMs) and their applications in different products, also as antibacterial additives, are increasing. In the present manuscript, according to an adverse outcome pathway (AOP) approach, we tested two safe-by-design (SbD) newly developed Ag NPs coated with hydroxyethyl cellulose (HEC), namely AgHEC powder and AgHEC solution. These novel Ag NPs were compared to two reference Ag NPs (naked and coated with polyvinylpyrrolidone—PVP). Cell viability, inflammatory response, reactive oxygen species, oxidative DNA damage, cell cycle, and cell–particle interactions were analyzed in the alveolar in vitro model, A549 cells. The results show a different toxicity pattern of the novel Ag NPs compared to reference NPs and that between the two novel NPs, the AgHEC solution is the one with the lower toxicity and to be further developed within the SbD framework.
Fichier principal
Vignette du fichier
2023_Motta_Toxics.pdf (6.63 Mo) Télécharger le fichier
Origine : Publication financée par une institution
licence : CC BY - Paternité

Dates et versions

hal-04003604 , version 1 (24-02-2023)

Identifiants

Citer

Giulia Motta, Maurizio Gualtieri, Melissa Saibene, Rossella Bengalli, Andrea Brigliadori, et al.. Preliminary Toxicological Analysis in a Safe-by-Design and Adverse Outcome Pathway-Driven Approach on Different Silver Nanoparticles: Assessment of Acute Responses in A549 Cells. Toxics, 2023, 11 (2), pp.195. ⟨10.3390/toxics11020195⟩. ⟨hal-04003604⟩
12 Consultations
13 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More